Cargando…
Therapeutic approaches for SARS-CoV-2 infection
Therapeutic approaches to COVID-19 treatment require appropriate inhibitors to target crucial proteins of SARS-CoV-2 replication machinery. It’s been approximately 12 months since the pandemic started, yet no known specific drugs are available. However, research progresses with time in terms of high...
Autores principales: | Gupta, Ankur, Pradhan, Anish, Maurya, Vimal K., Kumar, Swatantra, Theengh, Angila, Puri, Bipin, Saxena, Shailendra K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096528/ https://www.ncbi.nlm.nih.gov/pubmed/33962011 http://dx.doi.org/10.1016/j.ymeth.2021.04.026 |
Ejemplares similares
-
Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection
por: Kumar, Swatantra, et al.
Publicado: (2020) -
Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Kumar, Swatantra, et al.
Publicado: (2020) -
Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
por: Kumar, Swatantra, et al.
Publicado: (2020) -
Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
por: Saxena, Shailendra K., et al.
Publicado: (2020) -
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
por: Maurya, Vimal K., et al.
Publicado: (2020)